References
- Kloner RA, Zusman RM. Cardiovascular effects of sildenafil citrate and recommendations for its use. Am J Cardiol 1999;84:11-17N
- Emmick JT, Stuewe SR, Mitchell M. Overview of the cardiovascular effects of tadalafil. Eur Heart J Supplements 2002;4:H32-47
- Reffelmann T, Kloner RA. Vardenafil: a selective inhibitor of phosphdiesterase-5 for the treatment of erectile dysfunction. Expert Opin Pharmacother 2007;8:965-74
- Reffelmann T, Kloner RA. Cardiovascular effects of phosphodiesterase 5 inhibitors. Curr Pharmaceutical Design 2006;12:3485-94
- Kloner RA, Jackson G, Emmick JT, et al. Interaction between the phosphodiesterase 5 inhibitor, tadalafil, and the 2 a-blockers doxazosin and tamsulosin in healthy normotensive men. J Urol 2004;172:1935-40
- Webb DJ, Muirhead GJ, Wulff M, et al. Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina. J Am Coll Cardiol 2000;36:25-31
- Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003;89:251-3
- Kostis JB, Jackson G, Rosen R, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 2005;96:313-21
- Bacon CG, Hu FB, Giovannucci E, et al. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care 2002;25:1458-63
- Sefterl AD, Sun P, Swindle R. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol 2004;171:2341-5
- Eng P, Ma M, Zhang X, et al. Codispensing of tadalafil and other phosphodiesterase type 5 inhibitors with contraindicated organic nitrates. Pharmacoepidemiol Drug Saf 2008;17:S1:246
- Tobi H, Faber A, van den Berg PB, et al. Studying co-medication patterns: the impact of definitions. Pharmacoepidemiol Drug Saf 2007;16:405-11
- Williams D, Feely J. Initial uptake in use of sildenafil in general practice. Eur J Clin Pharmacol 2001;56:911-14
- Cheitlin MD, Hutter AM, Brindis RG, et al. Use of sildenafil (Viagra) in patients with cardiovascular disease. J Am Coll Cardiol 1999;33:273-82
- Kloner RA, Hutter AM, Emmick JT, et al. Time course of the interaction between tadalafil and nitrates. J Am Coll Cardiol 2003;42:1855-60